Catalina Gorla serves as the Chief Executive Officer for TruDataRx. In this role, Catalina works closely with the clinical team and clients of TruDataRx to ensure an exceptional customer experience that results in meaningful savings in pharmacy benefits driven by rigorous evidence-based analytics. Catalina also works with the TruDataRx development team to build the analytical tools and software that drive the value for clients.

Catalina has spent over 12 years working in healthcare in a range of roles involving research commercialization, enterprise formation, and operations development. Prior to founding TruDataRx, Catalina was the founding COO of Informulary, Inc, a company committed to improving health by providing doctors and patients with the information they need to make wise decisions about prescription drugs and also held positions at Dartmouth College as the Program Manager of innovations in translation and new initiatives at the Dartmouth Center for Healthcare Delivery Science. Through these roles, Catalina worked with researchers and business professionals to create self-sustaining entities that address needs in the health care delivery system. Prior to Dartmouth, she worked as an economist for a large investment management firm, focusing on international financial markets. In this role, she developed new tools and analytical reports on investable foreign markets. Prior to her work in economic research, Catalina completed a financial leadership rotation program in the insurance industry. Catalina graduated cum laude from Dartmouth College.